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Distortion product otoacoustic emissions in patients with haemophilia 
Leung Hei Tin 
Abstract 
This study investigated the cochlear function of 13 haemophilic patients using distortion product 
otoacoustic emission (DPOAE) assessment techniques. Out of the 26 ears examined, a minority 
of them produced responses that were considered to be impaired. A positive correlation was 
found between clotting factor level and DPOAE amplitude, and DPOAE/ noise ratio at high 
frequencies (4, 6, 8 kHz). Clotting factor level, which is indicative of the severity of 
haemophilia, may be related to hearing status. It was also revealed that DPOAE amplitude and 
DPOAE/ noise ratio at low frequencies (1, 2, 3 kHz) were greater than those at high frequencies 
(4, 6, 8 kHz). Therefore the high-frequency cochlear region may be more sensitive to damage. 
Intracranial micro-haemorrhage in haemophilic individuals may be linked to an increased risk of 
cochlear damage. Further studies may use brain computed tomography scan to explore the 
possible link between intracranial micro-haemorrhage and hearing loss.  
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Distortion Product Otoacoustic Emissions in Patients with Haemophilia 
Introduction 
Coagulation is an important part of haemostasis, which refers to the process that stops 
bleeding (McKenzie, 1996). Two common congenital coagulation disorders are haemophilia and     
von Willebrand disease.  
Haemophilia is an x-linked genetic condition in which a clotting factor is partially or 
completely missing (Canadian Hemophilia Society, 2001). It is more likely to occur in males 
than females. Most of the females with the defective gene become an asymptomatic carrier of the 
condition. There are two main types of haemophilia. The most common type is haemophilia A, 
in which coagulation factor VIII is lacking. It is five times more common than haemophilia B, in 
which coagulation factor IX is lacking. With the defect of a coagulation factor, a haemophiliac 
individual bleeds for longer than normal. Complications of the condition may include joint 
disease, deep internal bleeding, blood-borne infection and intracranial hemorrhage (Canadian 
Hemophilia Society, 2001). At the end of 2008, Hong Kong had a population of 6 988 900 
(Census and Statistics Department, 2008). Based on an incidence rate of about 5 in 100 000 
(Nathwani & Tuddenham, 1992), approximately 350 people are affected with haemophilia in 
Hong Kong.  
Von Willebrand disease is more common and usually milder than haemophilia. It is 
caused by a problem with the von Willebrand factor which is essential for proper blood 
coagulation. Among the three types of the disease (Type 1, Type 2 and Type 3), Type 3 is the 
most severe form. Symptoms usually include easy bruising and prolonged bleeding (Page, 2007). 
The prevalence of clinically significant cases of von Willebrand disease is 1 in 10 000 (Rodrigo, 
2004). Hence it could affect as many as 700 Hong Kong people.  
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Research describing hearing disorders in patients with haemophilia and other congenital 
coagulation disorders is scarce. Fabiani and colleagues (1985) first observed a non-age linked 
hearing loss in haemophilic individuals and carried out a more thorough investigation using 
otological examination, pure-tone audiology, impedance tests and auditory brainstem-evoked 
responses. The subjects were divided into two groups based on the severity of the congenital 
coagulation disorder. The 18 patients in the first group had mild haemophilia or von 
Willebrand’s disease, while the 22 patients in the second group had severe haemophilia. From 
the results, 61% of the ears in the mild group and 40.9% of the severe group were found to have 
hearing loss greater than 15 dB HL. The pathologies found were mainly cochlear and mixed 
cochlear-retrocochlear in nature. From the results of the auditory brainstem-evoked (ABR) tests, 
it was shown that brainstem auditory pathway damage was localized in the rostral brainstem 
region. This localization was also indicated in the study by Thomas and colleagues, who 
examined 22 subjects with congenital coagulation disorder (Thomas, McPherson, McWhirter, & 
McGill, 1992). The patients underwent pure-tone audiometry, tympanometry and acoustic reflex 
measures, speech audiometry, staggered spondaic word list, synthetic sentence identification test 
and masking level difference test. The results indicated a predominantly sensorineural hearing 
loss for high-frequency (>4 kHz) test tones and possible central auditory dysfunction. Fabiani et 
al. postulated that intracranial micro-haemorrhagic episodes that occur in patients with 
congenital coagulation disorders are linked to hearing loss. The nature of the dysfunction varies 
with the site of bleeding. As some areas, such as the stapes footplate, are more susceptible to 
haemorrhage than the others, high-frequency hearing loss may be more common in these 
individuals (Fabiani, et al., 1985).  
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The present study will contribute to the understanding of hearing loss associated with 
haemophilia by considering otoacoustic emissions (OAEs) in this group. OAE tests have not 
been carried out in this population. These tests can assess the functioning of the outer hair cells 
of the cochlea in a non-invasive and rapid manner, thus offering valuable information about the 
possible pathology in the inner ear. OAEs are acoustical signals that are emitted from the outer 
hair cells located in the cochlea (Kemp, 1997). Among the three types of OAE, distortion 
product otoacoustic emissions (DPOAEs) are measured in the current study for two reasons; they 
allow for greater frequency specificity and they can be used to test at higher frequencies (Gaskill 
& Brown, 1993).  
DPOAEs are generated by the nonlinear mechanism of cochlear activity. Cochlear 
nonlinearity originates from the outer hair cells of the cochlea. This refers to the cochlea’s 
disproportional output to its input. For low-level auditory inputs, the displacement of the basilar 
membrane is enhanced so that the output is amplified. However, the response becomes 
compressive when there is a moderate-level input (Popelka, Osterhammel, Nielsen, & 
Rasmussen, 1993). DPOAEs are generated as a by-product of this mechanism. When the cochlea 
is stimulated simultaneously by two pure tone frequencies (F1= lower frequency, F2 =higher 
frequency), their tonotopic representations along the cochlea might overlap. Distortion is 
generated if the overlap occurs at a place where the response to one of the tones is nonlinear. As 
the distortion is a by-product of the nonlinear mechanism that depends on the outer hair cell 
system, and since the outer hair cells are vulnerable to essentially all cochlear impairments, 
absent or abnormal DPOAEs are consistent with cochlear impairment.  
The measured DPOAE level systematically depends on the four parameters of the 
stimulus tones, i.e., the levels of the primary tones (L1, L2), the L2-L1 level difference, the 
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absolute stimulus frequencies (f1, f2) and the frequency-separation ratio (f2/f1). For the 
intensity-related factors, it is known that the largest DPOAEs are elicited by primary tones at 65 
and 55 dB SPL, with the L2-L1 level difference being 10 dB (Gaskill & Brown, 1990; Hauser & 
Probst, 1991; Whitehead, McCoy, Lonsbury-Martin, & Martin, 1995). For the frequency-related 
parameters, the most robust of the distortion products occurs at a frequency equal to 2f1-f2, and 
the frequency ratio of 1.22 results in the largest distortion product (Brown, Sheppard, & Russel, 
1994; Gaskill & Brown, 1993). So these settings were followed for the DPOAE measurements in 
this study.  
Figure 1 and figure 2 show two DP-grams generated with the above parameters. The 
upper line shows the intensity of the distortion product across the stimulus frequencies while the 
filled area indicates the noise level. The DPOAEs in Figure 1 is more robust than that in Figure 2 
as both the DPOAE amplitude and DPOAE/ noise ratio (the difference between DPOAE 
amplitude and noise floor) are larger.  
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 Figure 1 and 2. Two sample DP-grams. DPOAEs were elicited at 2 points per octave from 1-8 
kHz (f2/f1= 1.22) by primary tones where L1-L2 = 10dB;  L1= 65dB, L2=55dB. The upper line 
shows the intensity of the distortion product across the stimulus frequencies while the filled area 
indicates the noise level. The lower and upper filled area represents the mean noise floor + 1 SD 
and + 2 SDs respectively. 
In general, the presence of normal DPOAE responses across 1-4 kHz, which is the speech 
frequency range, indicates normal function in both the middle ear and the cochlea (Kemp, 2002). 
Two common approaches are used to distinguish between normal and impaired DPOAE 
responses.  
The first one is to make the decision based on the DPOAE/ noise ratio. Ears that produce 
a DPOAE/ noise ratio that is larger than a certain criterion are considered normal. The criterion 
may be set at 6 dB for clinical purposes and 3 dB for a less stringent standard. However, this rule 
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may be too simplistic as the DPOAE/ noise ratio depends on the noise level, which is relevant to 
the surroundings but irrelevant to cochlear status (Robinette & Glattke, 2007). If two persons 
produce a DPOAE response of 0 dB SPL with a noise level of 0 and -10 dB SPL, respectively, 
the former case will be considered impaired while the latter will be considered normal. In the 
latter case, the 10 dB DPOAE/ noise ratio is likely to be inflated by the low level of noise. 
Therefore, using the DPOAE/ noise ratio criteria may produce inaccurate results due to the 
inconstant noise level. 
There is another approach that only uses the DPOAE response level as the criterion 
measure. By plotting the normal distribution of DPOAE response amplitude for the normal and 
impaired population on the same graph, one could argue that responses above the 95th percentile 
of the impaired population are likely to be coming from an ear with a normal hearing status 
because so few individuals with impaired hearing could produce DPOAEs of that magnitude or 
greater. By the same token, any individual who produces DPOAE response amplitudes below the 
5th percentile for normal ears would be consistent with having impaired hearing because so few 
individuals with normal hearing produce DPOAEs that small.  The advantage of this approach is 
that it addresses the overlap between distributions of responses from normal and impaired ears, 
which is inevitable in reality. But, any responses falling between the 5th percentile for normal 
ears and 95th percentile for impaired ears will be rendered uninterpretable under this approach.  
Hypotheses of current study 
There are two null hypotheses in this study. The first null hypothesis is that there is no 
significant difference in the prevalence of cochlear hearing loss between patients with 
haemophilia and normal subjects. Sensorineural hearing loss is indicated by a reduction in 
DPOAE level due to reduced outer hair cell activity. It is expected that the DPOAE response 
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level across frequencies will be significantly lower in amplitude in patients with haemophilia 
than in normal subjects. The second null hypothesis is that there is no significant difference in 
the prevalence of high frequency (4, 6, 8 kHz) and low frequency (1, 2, 3 kHz) cochlear hearing 
loss in patients with haemophilia. It is expected that the DPOAE response level in the high 
frequency region will be significantly lower in amplitude than that in the low frequency region, 
because it was suggested that some areas, such as the stapes footplate, are more susceptible to 
haemorrhage (Fabiani, et al., 1985) 
Methodology 
Subjects 
Thirteen young adults with haemophilia were recruited as participants with the help of 
the Hong Kong Haemophilia Society. An inclusion criterion was that all subjects should be aged 
between 15 to 35 years of age. This was to avoid any effects of presbycusis. Subjects who were 
infected with the human immunodeficiency virus (HIV) or suffer from acquired 
immunodeficiency syndrome (AIDS) were excluded as HIV/ AIDS are proven to be associated 
with hearing loss (Sooy, 1987). Another exclusion criterion was that subjects with prior 
occupational exposure to loud noise were not included so as to eliminate the possibility of noise-
induced hearing loss. None of the subjects had any pathologic conditions of the external or 
middle ear, as they passed a hearing screening protocol with the following criteria (see Table 1); 
 
 
 
 
Tests  Criteria  
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Table 1. Passing criteria for the hearing screening 
 
Equipment 
All the tests were performed in the Standard Chartered Community Foundation Hearing 
Centre of the University of Hong Kong. The equipment used included: a Welch Allyn (New 
York, U.S.A.) fibre-optic otoscope (3.5V nickel-cadmium rechargeable handle); GN Otometrics 
(Taastrup, Denmark) diagnostic audiometer (Madsen Itera II, model: 1004) calibrated to 
accepted standards of ANSI s3.22-1996; Grason Stadler (New Hampshire, U.S.A.) middle ear 
analyzer (GSI 33, model: 1733) calibrated with GSI test cavities (model: 1733-1035) of 2cc for 
226 – 678 Hz; and an Otodynamics (Herts, United Kingdom) ILO OAE system (Echoport 
ILO288 USB-I) with ILO v6 software and general double probe (UGD-USB) calibrated in a 1cc 
test cavity. 
 Procedures  
After case-history taking and hearing screening which included otoscopic examination, 
tympanometry and pure-tone audiometry, distortion product otoacoustic emission testing was 
carried out. Probe fit was checked before otoacoustic emission recording and a stimulus with the 
properties listed in Table 2 was given. 3 sweeps across the frequency range was taken in each 
Otoscopic examination   Normal and clear external ear canal and an intact tympanic membrane 
Tympanometry 
 
1. Jerger Type A tympanogram 
2. Tympanic compliance between 0.2cm
3
 and 2cm
3
 
3. Peak middle ear pressure in the range of +50 and -100 daPa 
Pure-tone audiometry 
 
No threshold greater than 20 dB HL for two or more frequencies, nor 
any threshold with an air-bone gap of 10 dB or greater  
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measurement. DPOAE amplitudes and the noise level were recorded for subsequent data 
analysis.  
Table 2. Properties of the testing stimulus 
 
Data & statistical analysis 
Statistical analyses were performed using SPSS 15.0 for Windows. Descriptive statistics 
such as mean and median were used to show the gender and type of haemophilia of the subjects. 
For the first hypothesis, the amplitude of DPOAEs in patients with haemophilia was compared 
with two data points (5th percentile for normal ears and 95th percentile for impaired ears) of a 
large sample of normal subjects (Gorga et al., 1997). No inferential tests could be done due to the 
small study group sample size. The amplitude of DPOAEs in patients with haemophilia in the 
high frequency region was compared with that in the low frequency region by paired t-test. The 
effect of subject ear on DPOAE amplitude and DPOAE/ noise ratio was examined by a paired-
sample t-test as it was suggested that DPOAEs tend to be larger for right than for left ears 
(Stover & Norton, 1993). The effect of age on the two variables was tested by Pearson product-
moment correlation to see if the same effect found in Lonsbury-Martin & Martin’s study (that 
DPOAE levels tends to decrease with increase age) would be found (Lonsbury-Martin & Martin, 
Sound stimuli 2 pure tones 
Frequency 1, 1.5, 2, 3, 4, 6, and 8 kHz 
Frequency ratio 1.22 
Intensity (dB) L1= 65dB; L2=55dB 
Points per octave 2 
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2007). Pearson product-moment correlation was also computed to examine if there were 
significant effects of the type of haemophilia and the percentage of clotting factor on DPOAEs. 
Results 
Table 3 shows the demographic information of the subjects and Table 4 shows the mean, 
standard deviation, and 95% confidence interval for the amplitude of DPOAEs and DPOAE/ 
noise ratio for the subjects.  
Table 3. Demographic information (age, gender and type of haemophilia) of the subjects 
Age in years Number Total sample % 
15-19 1 8 
20-24 6 46 
25-29 5 38 
30-35 1 8 
Gender   
Male 13 100 
Type of haemophilia   
Haemophilia A 10 77 
Haemophilia B 3 23 
 
Table 4. The mean, standard deviation, and 95% confidence interval of the amplitude of 
DPOAEs and DPOAE/ noise ratio.  
 Mean SD 95% CI 
DPOAE 2.68 10.21 -2.87-8.23 
DPOAE/ noise ratio 14.37 9.91 8.98-19.76 
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Effect of subject ear  
A paired-sample t-test was used to find if there was any difference in DPOAE amplitude 
and DPOAE/ noise ratio between left and right ear. No significant difference was found for both 
DPOAE amplitude (t (91) = 1.34, p > .05) and DPOAE/ noise ratio (t (91) = 0.61, p > .05). 
DPOAE amplitude and DPOAE/ noise ratio at high and low frequencies 
In this experiment, response was measured at seven frequencies, 1, 1.5, 2, 3, 4, 6, and 8 kHz. 
Among them, 1, 2, 3 kHz were defined as low frequencies while 4, 6, 8 kHz were labeled as high 
frequencies. The mean DPOAE amplitude at low frequencies (mean= 4.74, SD= 6.27) was 
greater than that at high frequencies (mean= -0.61, SD= 6.16). Similarly for DPOAE/ noise ratio, 
responses at low frequencies (mean= 15.70, SD= 7.14) was greater than that at high frequencies 
(mean= 12.61, SD= 6.26). A paired-sample t-test was used to find if there was any difference in 
DPOAE amplitude and DPOAE/ noise ratio at high and low frequencies. A significant difference 
was found for both DPOAE amplitude (t (25) = 4.75, p < .01) and DPOAE/ noise ratio (t (25) = 
2.38, p < .05). 
Effect of age on DPOAE amplitude and DPOAE/ noise ratio  
A Pearson product-moment correlation was conducted to determine if there is a 
relationship between age and DPOAE amplitude. There was a small negative correlation 
between the two variables (r (180) = -0.215, p < .01). The same was found for DPOAE/ noise 
ratio (r (180) = -0.218, p < .01). 
Effects of type of haemophilia 
A Pearson product-moment correlation was performed to examine the relationship 
between the type of haemophilia (type A and type B) and DPOAE amplitude, and between the 
type of haemophilia (type A and type B) and DPOAE/ noise ratio. No correlation was found. 
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Effect of the percentage of clotting factor on DPOAEs  
Eight of the thirteen subjects reported their personal level of clotting factor (%). A 
Pearson product-moment correlation was calculated to investigate the relationship between the 
percentage of clotting factor and DPOAE amplitude at high frequencies, low frequencies and all 
frequencies in average. The same was calculated for the DPOAE/ noise ratio. A moderate degree 
of correlation was found between the percentage of clotting factor and DPOAEs at high 
frequencies only [DPOAE amplitude: (r (14) = 0.684, p < .01); DPOAE/ noise ratio:  r (14) = 
0.681, p < .01)]. Figure 3 shows the scatterplot of DPOAE amplitudes at high frequencies 
against the percentage of clotting factor. 
Figure 3 Scatterplot of DPOAE amplitudes at high frequencies against clotting factor level. 
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Comparison with a large sample of normal and impaired ears (Gorga, et al., 1997) 
Gorga et al (1997) defined any DPOAE amplitude above the 95
th
 percentile of the 
impaired population as normal hearing because so few individuals with hearing loss can produce 
DPOAEs of that magnitude or larger. By the same token, DPOAEs below the 5
th
 percentile of 
the normal population are considered to be coming from an ear with impaired hearing as few 
individuals with normal hearing produce DPOAEs with such a small value. Figure 4 and 5 show 
the boxplots of DPOAE amplitude and DPOAE/ noise ratio against F2 frequency respectively, 
alongside with the 95
th
 percentile of the impaired population and the 5
th
 percentile of the normal 
population. 
 
 
 
 
 
 
 
 
 
 
 
 
Figure 4. Boxplot of DPOAE amplitude against F2 frequency. 
 haemophilic  
individuals 
 95th percentile 
of the impaired 
population 
 5th percentile of 
the normal 
population 
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Figure 5. Boxplot of DPOAE/ noise ratio against F2 frequency. 
Only DPOAE amplitudes were considered when judging the normality of the 26 ears across the 7 
frequencies. Amplitudes above the 95
th
 percentile of the impaired population were viewed as 
normal. The results are shown in Table 5.  
Table 5. Number of impaired ears (out of a total of 26 ears) across 7 frequencies based on the 
criteria of Gorga et al. (1997).  
 
 
 
a 
 Refers to the mean of the 7 frequencies 
Frequency (Hz) 1000 1500 2000 3000 4000 6000 8000 Average
a
 
Number of impaired ears 2 1 1 0 1 2 0 1 
 haemophilic  
individuals 
 95th percentile 
of the impaired 
population 
 5th percentile of 
the normal 
population 
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Discussion 
Effect of subject ear  
Stover and Norton (1993) found that DPOAEs tend to be larger for right than for left 
ears. This was not observed in the present study. The reason may be that the sample size is too 
small to detect the slight effect previously noted.  As no significant difference was found, subject 
ear was not considered as a variable in the analysis that followed. 
DPOAE amplitude and DPOAE/ noise ratio at high and low frequencies 
Thomas et al. (1992) suggested that high-frequency hearing loss is more common in 
haemophilic individuals because some areas, such as the stapes footplate, are more susceptible to 
bleeding. This same trend was also found in the current study—that DPOAEs at low frequencies 
were higher than those at high frequencies. However, brain computed tomography (CT) scans 
may be required if one wants to identify the sites and extent of the intra-cranial hemorrhage 
(Kinney, Zimmerman, Butler, & Gill, 1977). With that information, the link between hearing 
loss and intra-cranial bleeding can possibly be established. 
Effect of age on DPOAE amplitude and DPOAE/ noise ratio  
In this study, only individuals aged between 15 to 35 years were recruited so as to 
eliminate the possible effects of presbycusis. A negative correlation was found between age and 
DPOAE amplitudes. This echoes the result reported in a recent study (Lonsbury-Martin & 
Martin, 2007). However, Stover and Norton (1993) found that the influence of age on DPOAEs 
is negligible, given that the influence of age and hearing level on DPOAEs were analyzed 
separately. Future studies have to be better controlled with respect to the individuals’ hearing 
level in addition to age before a reliable conclusion can be drawn. 
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Effects of the type of haemophilia  
No effects of the type of haemophilia were found. But due to the small sample size, the 
results may be inconclusive as slight effects may not be detected. 
Effect of percentage of clotting factor on DPOAEs  
Thomas et al. (1992) found that the extent of hearing loss was greater in patients with 
mild congenital coagulation disorders than those with moderate and severe disorders. The current 
result contradicts their work, as a positive correlation was found between the percentage of 
clotting factor and DPOAEs at high frequencies. The higher the clotting factor level (and hence 
the milder the disorder), the greater the amplitude of DPOAEs recorded. However, as the 
correlation was only of a moderate level and was only shown in the high frequency region, this 
may be related to the suggestion that some regions (such as the stapes footplate) may be more 
susceptible to damage than the others (Thomas et al., 1992).  
Comparison with a large sample of normal and impaired ears  
Although both DPOAE amplitudes and DPOAE/ noise ratios were recorded in the study, 
only the DPOAE amplitudes were considered when judging the normality of the ears because the 
DPOAE/noise ratios depend on the noise level of the environment, which is irrelevant to the 
individual’s hearing status (Robinette & Glattke, 2007). Based on the criteria of Gorga et al. 
(1997), ears with DPOAEs below the 5
th
 percentile of the normal population were considered 
impaired. Out of the 26 ears examined, only one of them was regarded as impaired when the 
average result of the 7 testing frequenies was considered. Less than 3 ears produced responses 
that were considered to be impaired in any of the 7 test frequencies. 
Four outliers with particularly low DPOAE amplitudes were observed in Figure 4. Further 
investigations were made to reveal any trends present. However, it was found that the four points 
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had little in common as they occur at different frequencies (2, 3 and 6 kHz, respectively); they 
were from four different individuals and the clotting level of two of the four individuals were 
unknown (see Table 6).  
Table 6. Information of the four outliers observed in Figure 4 
Subject number F2 frequency (kHz) DPOAE amplitude  
(dB SPL) 
Clotting factor level of the subject  
122 2 -30.00 unknown 
39 3 -13.30 unknown 
139 6 -20.20 2% 
83 6 -22.00 1% 
 
Limitations of the present study and future study  
The sample size of this study was quite small and reliable inference often could not be 
made. For example, the prevalence rate of hearing loss between patients with haemophilia and 
normal subjects could not be compared. Also, subtle trends may have been missed due to the 
reduced sensitivity of the small sample. Future studies should include a larger number of subjects 
so that valid conclusions can be drawn. Female carriers of the defective gene and patients of von 
Williebrand’s disease should also be included so as to study the effects of gender and type of 
congenital coagulation disorder on DPOAEs. Besides, only 8 of the 13 subjects reported their 
level of clotting factor. Meaningful conclusions could not be made due to the incompleteness of 
the data. As the percentage of clotting factor was by self-report only, the reliability of the data is 
debatable due to possible memory flaws.   
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Conclusion 
The current study offers some preliminary data about the hearing status of patients with 
haemophilia. DPOAE tests were used as they could examine functioning of the outer hair cells of 
the cochlea in a non-invasive and objective manner. Out of the 26 ears examined, only a minority 
of them produced DPOAEs that were lower than those of the impaired population. A positive 
correlation was found between the percentage of clotting factor and DPOAEs at high 
frequencies. The test results also revealed that DPOAEs at low frequencies were significantly 
greater than those at high frequencies. Although no definite conclusion can be drawn from this 
small-scale study, it appears that clotting factor level may be related to hearing status, and that 
the high-frequency region of the haemophilic individuals may be more sensitive to damage. This 
topic should be explored more fully by involving a larger sample pool. Brain computed 
tomography (CT) scans may also be carried out if one wants to identify the sites and extent of the 
intra-cranial hemorrhage. With that information, the link between hearing loss and intra-cranial 
bleeding can possibly be established. 
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Appendix A 
Informed Consent Form 
You are cordially invited to participate in a research study titled ‘Distortion product otoacoustic 
emissions in patients with haemophilia.’ Distortion product otoacoustic emissions (DPOAEs) 
test is a standard audiological test that evaluates the functioning of outer hair cells of the inner 
ear. This study aims at evaluating the auditory system of patients with haemophilia by testing 
distortion product otoacoustic emissions. Distortion products (DP) are faint sounds, produced by 
normal cochlea when two pure tones, slightly different in frequency, are simultaneously presented to 
the ear. The result of the distortion product otoacoustic emissions test will help to identify 
patients who are at risk for hearing impairment. 
In this study, hearing screening (20 mins) which includes pure tone audiometry and 
tympanometry will be carried out. Pure tone audiometry identifies the hearing threshold levels of 
an individual; while tympanometry measures the aural acoustic immittance as a function of the 
ear canal pressure. Upon passing the screening, you will be invited to have a DPOAE test for 
both ears (15 mins). The DPOAE test is conducted by inserting a soft silicone probe with 
miniature microphone into the entrance of external ear canal. The cochlea will be stimulated 
simultaneously by two tones of different frequencies. The responses from the cochlea will then 
be recorded. No potential risks or discomfort will be caused. 
All the information obtained in this study will remain strictly confidential and will be used for 
research purposes only. Your participation in this project is voluntary. This means that you can 
withdraw from this project at any stage, for any reasons, without negative consequences. If you 
want to know more about the rights as a research participant, please contact the Human Research 
Ethics Committee for Non-Clinical Faculties, the University of Hong Kong (Tel: 2241 5267).  
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If you have any questions or concerns about the research, please feel free to contact the 
investigator Alice Leung Hei Tin (Tel: 6220 4624). 
--------------------------------------------------------------------------------------------------------------------- 
I, _______________________ (Name of Participant) understand the procedures described above 
and agree to participate in the study. 
 
 
 
 
Signature :  
 
Date 
 
: 
 
 
Contact number 
 
: 
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Appendix B 
同意書 
香港大學言語及聽覺科學部誠意邀請閣下參與一項名為「血友病人士的耳聲發射」的研
究。 
「耳聲發射」是常規的聽力檢查，主要測試耳蝸內毛細胞的功能。這項研究是透過「耳聲
發射」來測試血友病病人的內耳系統的狀況。研究的結果有助於確認可能患有聽力障礙的
病人。 
研究期間，參加者須要接受簡單的聽力篩檢(約20分鐘)。篩檢包括「純音測試」和「中耳
聲阻抗測驗」。「純音測試」可以評估參加者雙耳在各頻率的聽力表現，而「中耳聲阻抗
測驗」則可提供耳膜及中耳系統狀況的資料。 通過篩檢者將會被邀請參加這項「耳聲發
射」研究(約15分鐘)。研究員會把已接駁電腦的軟矽膠探嘴放進耳朵的外耳道口，探嘴會
發放兩個頻率不同的音，然後量度耳蝸的反射聲音。本測試不會構成不良或不適的反應。 
研究收集之所有資料只供香港大學作研究用途，並會絕對保密。此為自願的研究項目，參
加者可隨時終止測試，有關決定將不會引致任何不良後果。如閣下想知道更多有關研究參
與者的權益，請聯絡香港大學研究操守委員會(電話:2241 5267)。 
如對此項研究有任何疑問，請聯絡香港大學言語及聽覺科學部本科生梁曦田 (電話:6220 
4624)。 
--------------------------------------------------------------------------------------------------------------------- 
 
本人 _____________________(參加者姓名)明白測試的程序，並願意參加此項研究。 
 
 
參加者簽名 :  
 
日期 
 
: 
 
 
聯絡電話 
 
: 
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Appendix C 
Distortion product otoacoustic emissions in patients with haemophilia 
Case History Form 
Name:_______________________ Date of Birth:_____________________ Sex: M/F 
 
Haemophilia A   Haemophilia B   von Willebrand’s disease   Others  
 
Clotting factor level (%): ______________  Severity: mild/ moderate/ severe 
 
          Have you ever  
 
1 had hearing loss?      Yes     No      Details:  
2 had middle ear infection? Yes     No      Details:  
3 had an ear surgery? Yes     No      Details:  
4 had regular exposure to loud noise? Yes     No      Details:  
5 had a history of familial hearing loss? Yes     No      Details:  
6 been tested positive for HIV/AIDS? Yes     No      Details:  
 
Hearing Screening Recording Form 
 
 Otoscopic Examination 
 
 Tympanometry 
 Ear debris/ wax 
Other 
abnormalities 
 
Peak Compliance 
(ml) 
Peak Pressure 
(daPa) 
Jerger Type 
Right 
ear 
      
Left 
ear 
      
  CNE = cannot evaluate      = Pass     X = Fail 
 
Pure-tone Audiometry – AC 
Frequency 250 Hz 500 Hz 1 kHz 2 kHz 4 kHz 8 kHz 
Right ear       
Left ear       
Pure-tone Audiometry – BC 
Frequency 250 Hz 500 Hz 1 kHz 2 kHz 4 kHz 8 kHz 
Right ear       
Left ear       
                                                                            = Pass at 20dB HL     X = Fail at 20dBHL 
